neobookRx
GuidelinesIMCI

Initiating ART in Children

IMCI - Anti-retroviral therapy (ART)

Step 1 : Record Patient Details and History

Step 2: Decide if the Child has Confirmed HIV Infection

Step 3: Decide if the Caregiver is Able to Give ART

Step 4: Decide if a IMCI Nurse Should Initiate ART

Step 5: Assess and Record Baseline Information

Step 6: Start ART


image

Click here to open the above PDF

Follow the 6 Steps 

Step 1: Record Patient Details and History

Record the following information in the HIV clinical chart.

  • Patient details
  • Caregiver details: Details of primary and secondary caregiver
  • Past medical history:
    - Allergies
    - Mode of transmission
    - ARVs prior to ART start date including PMTCT prophylaxis
    - ART transfer in details
    - Disclosure status
    - Immunisation status (update from RTHB)
    - Past medical history including surgical history

Step 2: Decide if the Child has Confirmed HIV Infection

Infant/ child <18 months:

The first positive PCR test is confirmed with a second positive HIV PCR

  • Proceed to Steps 3 - 6 whilst awaiting second PCR result

Child >18 months:

Under 2 years: A positive rapid HIV antibody test is confirmed with a positive HIV PCR

Over 2 years: A positive rapid HIV antibody tests confirmed with a second positive HIV antibody test(rapid or ELISA)

  • If the first rapid HIV test is positive and the second test is negative (discordant), do an ELISA or refer
  • Send outstanding tests but proceed to step 3 while awaiting results

Step 3: Decide if the Caregiver is Able to Give ART

  • Check that the caregiver is willing and able to administer ART
  • Complete psychosocial readiness and social record sections in the HIV clinical chart
  • The caregiver should ideally have disclosed the child’s HIV status to another adult who can assist with providing ART (or be part of a support group)
  • If caregiver is willing and able to give ART, move to Step 4
  • If not, classify as HIV INFECTION not on ART, and provide care as outlined in HIV- follow-up

Step 4: Decide if a IMCI Nurse Should Initiate ART

  • Check for the following:
    - General danger signs or any severe classification
    - Infant <1 month of age
    - Child weighs less than 3 kg
    - TB
    - Fast breathing
    - Any WHO stage 4 condition
  • If any of these are present, refer to next level of care for ART initiation
  • If none present, move to Step 5

Step 5: Assess and Record Baseline Information

  • Nutrition assessment
  • Weight, height/ length, head circumference (if <2 years), MUAC
  • BMI or WFH z-score. Classify based on findings
  • Assess and classify for anaemia 
  • TB screening and TB contacts
  • Developmental screening, school attendance and school performance
  • WHO clinical staging
  • Baseline laboratory investigations:
Baseline Investigations
Done for
CD4 count and FBC/ Hb All children starting ART
Creatinine and eGFR  Children/ adolescents starting tenofovir (TDF)
Alanine Aminotransferase (ALT) On TB treatment or starting nevirapine (NVP)
  • If the child has severe acute malnutrition, severe anaemia (Hb < 7g/dl) or TB refer to the next level of care for management and for initiation of ART
  • If Hb is 7 g/dl - 11 g/dl, classify as anaemia and treat. Do not delay starting ART
  • Send any outstanding laboratory tests. If the child already meets the criteria for starting

Step 6: Start ART

  • ART regimens always include 3 drugs
  • See ART dosing and instructions
  • Remember to counsel the caregiver on how to give the drugs and possible side-effects
  • Remember to give cotrimoxazole
  • Give other routine treatments
  • Follow-up after one week
Weight/ Age
ART regimen
Age >1 month AND Weight 2.5 kg - < 20 kg Abacavir (ABC)
Lamivudine (3TC)
Lopinavir/ritonavir (LPV/r)
Weight 20 - < 35 kg OR Age < 10 yrs Abacavir (ABC)
Lamivudine (3TC)
Dolutegravir (DTG)
Age ≥10 years AND Weight ≥ 35 kg Tenofovir (TDF)
Lamivudine (3TC)
Dolutegravir (DTG)

 


Integrated Management of Childhood Illness 2022; Anti-Retroviral Therapy; Initiating ART in Children: Follow the 6 Steps


Last checked for updates: June 2023

Drugs mentioned

NeoHealth® ID 19072 · updated 8/21/2023